Cross-sectoral B2B matching event ‘Digitalisation in life sciences’

Estonia, Tartu

October 2020, set of 3 events on 7., 8. and 14.Oct 2020


Visionary seminar ‘Digitalisation in life sciences: Growing the future’

Digital event 

Wednesday 7.Oct 2020, 14-16.40 CET

The hybrid seminar will have a focus on the potential and possibilities within the subject “Digitalisation in Life Sciences” – initiating digital transformation and change management in the health sector, trying to foresee the next 5-10 years of development in the field. 

The visionary seminar is divided into two sessions, first presents different healthcare sector innovations, proven to be successful from Estonia and the second part consists of innovative presentations from the future of Healthcare.


Timings mentioned below are in CET time zone.

Session I – Healthcare innovation from Estonia

14:00-14:10 Sven Parkel, Tartu Health Cluster/Tartu BT Park „Introduction of Tartu Health Cluster”

14:10-14:30  Ain Aaviksoo, GuardTime, Estonia “Robust approach to the complex challenge of digitizing healthcare”

14:30-14:50 Tõnu Esko, Estonian Genome Center, Estonia, „Personalised medicine“

14:50-15:00 Q&A 

15:00-15:10 Tea/coffee break

Session II  – Future vision of healthcare 

15:10-15:40 Bart de Witte, Hippo AI Foundation, Germany, “Developing a more equitable society”

15:40-16.10 Liesbet Geris, Universities of Liège and Leuven, Belgium, “From eHealth to in silico medicine: unlocking the full potential of digitalisation”

16:10-16:30 Sachin Gaur, Innovatio Curis, India, „Digital health and health technologies“

16:30-16:40 Q&A

Please register to the event here.


Speakers of the visionary seminar

Ain Aaviksoo, MD MPH is the Chief Medical Officer of Guardtime Health. 
Prior to this he worked as Undersecretary for E-services and Innovation for the Estonian government overseeing the digital transformation and innovation of healthcare, labour and social matters. 
Dr Aaviksoo obtained MD from University of Tartu and MPH from Harvard University. 
He has earlier work experience as a physician, senior level civil servant, international level consultant on large system transformation and technology adoption in healthcare, health policy researcher, CEO of public policy think-tank Praxis and as a health-tech entrepreneur. 

Dr Aaviksoo has published over 20 peer-reviewed articles and contributed to several book chapters on health policy and e-health, he also regularly presents as invited keynote speaker on digital services and healthcare.

Tõnu Esko, PhD, is a Vice Director of Development and head of Estonian Biobank Innovation Center at Institute of Genomics, University of Tartu, where he holds Professor Human Genomics position genomics. Dr Esko is also a Research Scientist at the Broad Institute of Harvard and MIT, Cambridge, USA and visiting researcher at the Children’s Hospital Boston and Harvard Medical School, Boston, USA. He has founded and is co-leading several international consortia. He serves as Scientific Advisory Board member for several global companies.
The Estonian Biobank hosts a comprehensive data repository of 200,000 participants from Estonia. Over the past 13 years, Dr Esko has been coordinating Biobank R&D activities both in native Estonia and internationally, both in the academic and private sector. He has also been a crucial member of the Biobank’s strategic leadership team in areas of fundraising, investment decision making on IT, technology and data infrastructure, and building partnerships with leading academic and industry players. His team is contributing to the Estonian Precision Medicine Initiative related activities by developing computational algorithms and feedback reports for personalized medicine applications.
Currently his work at Estonian Biobank Innovation Center is focused on building public private partnerships both with early-stage startups, SMEs, global corporations and VC funds across the fields of HealthTech, BioTech and MedTech by utilizing the rich Estonian Biobank digital health repositories as well as world-class scientific expertise. His latest endeavor is to set up a holding company for University of Tartu, an entity to park IP and data access based equity from startups, accelerators and even VC fonds.

Bart de Witte, is one of Europe’s leading and awarded experts on the digital transformation of healthcare, and one of the most progressive forward thinkers focuses on finding alternative European strategies for the current postmodern world to create a more desirable future with greater social benefits. He is the initiator of the HIPPO AI Foundation in Berlin, which aims to establish the first global NGO for open source-based artificial intelligence in medicine. He is involved as a mentor for dozen digital health start-ups and lectures at various universities in Germany, Belgium, Switzerland, Austria and China. He co-founded the Digital Health Academy where he shares his knowledge to improve digital literacy.




Liesbet Geris is Collen-Francqui Research Professor in Biomechanics and Computational Tissue Engineering at the University of Liège and Leuven in Belgium.  Her research focusses on the multi-scale and multi-physics modelling of biological processes. Together with her team and their clinical and industrial collaborators, she uses these models to investigate the etiology of non-healing fractures, to design in silico potential cell-based treatment strategies and to optimize manufacturing processes of these tissue engineering constructs. Liesbet is scientific coordinator of the Prometheus platform for Skeletal Tissue Engineering (50+ researchers). She has edited several books on computational modelling and tissue engineering. She has received 2 prestigious ERC grants (starting in 2011 and consolidator in 2017) to finance her research and has received a number of young investigator and research awards from the in silico and regenerative medicine communities. She is a former member and chair of the Young Academy of Belgium (Flanders) and member of the strategic alliance committee of the Tissue Engineering and Regenerative Medicine Society. She is the current executive director of the Virtual Physiological Human Institute and in that capacity she advocates the use of in silico modeling in healthcare through liaising with the clinical community, the European Commission and Parliament, regulatory agencies (EMA, FDA) and various other stakeholders. Besides her research work, she is often invited to give public lectures on the challenges of interdisciplinary in research, women in academia and digital healthcare.

Sachin GaurDirector Operations, InnovatioCuris, is a researcher cum entrepreneur in space of mobile and Internet solutions. He was in top 10 innovators in India under India Innovates Growth Programme 2013 by FICCI. He is involved in multiple ventures in the domain of digital marketing, mobile solutions and the Internet of Things.

He has a double M.Sc.(tech) in Mobile Security and Cryptography from Aalto University, Finland and University of Tartu, Estonia. He has worked in past with organizations like Adobe, C.E.R.N. and in research at the Aalto University in security-related topics.

Also, he has a dozen patents issued/pending in USPTO apart from contributing book chapters in two books on topics of Innovation and Healthcare.


Matchmaking ‘Digitalisation in life sciences’

Digital event

Thursday, 8.Oct 2020, 14 CET – 15.Oct 14 CET

B2Meets platform (length 1 week)

14:00-14:05        Introduction and rules

14:05-14:15        EIT Health Bridgehead programme possibilities, Anna Werner, Bridgehead Global Programme Manager, Medical Valley EMN e.V.

EIT Bridgehead programmes are suitable for enterprises with less than 50 employees that are active in the fields of MedTech, BioTech and Digital Health, are incorporated in an H2020-eligible country, and are operating in an EU country.

14:15-14:25        Advantages of cooperation in the life science sector, Neil Thomas, founding team member of ZipPrime and a partner in Ventac Partners, CBO of Idogen AB, Sweden and CBO of the Cube Labs group of companies, Italy

8.Oct 14:25 – 15.Oct 14:00 Pitching and matchmaking of SMEs in the Life Science sector on B2Meets platform

Companies participating in the matchmaking can enter their description, keywords (for automated search), and 2′ pitch. Matches and first contacts can be made on the same platform.

Please register to the event here.


Crash Course on Internationalisation

Digital event

Wednesday, 14.Oct 2020, 14 CET-16 CET

14:00-14:10        Introduction

14:10-14:30        Entering the Estonian market of (digital) life science. Specifics of this market: ecosystem, opportunities, subventions.                               Speaker: Sven Parkel, Tartu BT Park

14:30-14:40        Experience story of SMEs entering Estonia’s (digital) life science sector. Speaker: Neil Thomas, founding team member of ZipPrime and a partner in Ventac Partners, CBO of Idogen AB, Sweden and CBO of the Cube Labs group of companies, Italy

14.40-14:50        Experience sharing of the participants about entering the Estonian market in (digital) life science.

 14:50-15:00     Break

15:00-15:15        Entering other European and/or international markets in (digital) life science: general overview. Speaker: Sachin Gaur, Innovatio Curis

15:15-15:35        Entering and working on the Indian and Australian (digital) life science market. Speaker: TBC, Cases

15:35-15:50        Experience sharing of participants about entering other European and/or international markets.

15:50-16:00        Q&A – Round up


Please register to the event here.


Participation in the event is without a fee.

Information about CELIS project can be found here


CELIS is funded by the European Union’s COSME Programme (GA No.: 873857)CELIS is funded by EU COSME programme



The content of this website represents the views of the author only and is his/her sole responsibility; 
it cannot be considered to reflect the views of the European Commission and/or the Executive Agency
 for Small and Medium-sized Enterprises (EASME) or any other body of the European Union. 
The European Commission and the Agency do not accept any responsibility for use that may be 
made of the information it contains.